Section 5B - Data Collection (Phase 3 - 1/2011, rev. 8/2011)
Section 5B - Page 10
Cohort
Study
iv)
Topic 4: Transition experience for those who have changed care providers. We
will add 3 questions about the transition process for those who reported a change
in provider.
5.1.17.
Validation sub-study: comparison of participant responses and medical records
Participant/parent self-report of medical events and health care received is imperfect.
Self-report may be limited by several factors, including the desire to give the correct or
socially-desirable response, recall of events, and awareness of the services received.
Further, recall accuracy may vary based on sociodemographic characteristics, such as
education and income and the age of the respondent. In a study that compared recall of
ambulatory care services by adults with chronic health conditions with medical record
review, the authors suggested that recall of “memorable”
services, such as blood pressure
measurement, may be substantially better than for more invisible services, such as
specific tests being done using a blood sample
(47)
.
It is not feasible to conduct complete medical record reviews on all SEARCH Cohort
Study participants. Therefore, we will conduct a sub-study to validate self-report of key
medical events and selected markers of health care quality against clinical medical
information in the medical record. Specifically, we will validate episodes of acute
hypoglycemia requiring medical assistance (ED visit or hospitalization), DKA, ED visits,
and hospitalizations. To evaluate the validity
of these data elements, we will use
information in the medical record (including information stored in electronic health
records and clinical databases) to assess the frequency of these services compared to the
frequency reported on the survey. A random sample of 25 charts for each center (total of
1250 records) will be reviewed to assess the concordance. With this number we can
estimate 95% confidence intervals for the true concordance rate within +/- 20% for each
site, and overall, if we find that the sites have consistent levels of concordance, we can
estimate the 95% confidence interval for the true concordance within +/-8%. In addition
to examining the concordance rates, we will examine kappa statistics both within sites
and overall t o see what level of agreement exists.
5.2.
EXPANSION OF REPOSITORY
OF BIOLOGICAL SPECIMENS
The Northwest Lipid Metabolism and Diabetes Research Laboratories (NWRL) has been the
Central Laboratory for the SEARCH for Diabetes in Youth Study since its inception. In
addition to performing analysis, the laboratory has stored, processed, and retrieved serum,
plasma, urine and DNA samples collected from study participants for analysis at NWRL and
other laboratories participating in SEARCH ancillary studies. From the SEARCH Cohort Visit
we will supplement this repository with additional stored plasma, serum, urine and DNA.
Through the well-established SEARCH Ancillary Study policies, we encourage investigators
outside of the SEARCH team to utilize this resource.
Section 5B - Data Collection (Phase 3 - 1/2011, rev. 8/2011)
Section 5B - Page 11
Cohort
Study
Reference List
1.
Wenzlau JM, Liu Y, Yu L, Moua O, Fowler KT, Rangasamy S, Walters J, Eisenbarth GS,
Davidson HW, Hutton JC. A common nonsynonymous single
nucleotide polymorphism in
the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes.
Diabetes
2008 Oct;57(10):2693-7.
2.
Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White
NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS. Patterns of metabolic
progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.
Diabetes Care
2006;29(3):643-9.
3.
Albers JJ, Marcovina SM, Imperatore G, Snively BM, Stafford J, Fujimoto WY,
Mayer-
Davis EJ, Petitti DB, Pihoker C, Dolan L, Dabelea DM. Prevalence and determinants of
elevated apolipoprotein B and dense low-density lipoprotein in youths with type 1 and type
2 diabetes.
J Clin Endocrinol Metab 2008 Mar;93(3):735-42.
4.
Heding LG. Radioimmunological determination of human C-peptide in serum.
Diabetol
1975 Dec;11(6):541-8.
5.
Mayer-Davis EJ, Beyer J, Bell RA, Dabelea D, D'Agostino R, Jr., Imperatore G, Lawrence
JM, Liese AD, Liu L, Marcovina S, Rodriguez B. Diabetes in African American youth:
prevalence, incidence, and clinical characteristics: the SEARCH
for Diabetes in Youth
Study.
Diabetes Care 2009 Mar;32 Suppl 2:S112-S122.
6.
Mayer-Davis E, Nichols M, Liese AD, Bell R, Dabelea D, Johansen J, Pihoker C, Rodriguez
BL, Thomas J, Williams DE. Dietary Intake Among Youth With Diabetes: the SEARCH for
Diabetes in Youth Study.
JADA 2006 May;106(5):689-97.
7.
Cheng YJ, Gregg EW, Geiss LS, Imperatore G, Williams DE, Zhang X, Albright AL,
Cowie CC, Klein R, Saaddine JB. Association of A1C and fasting
plasma glucose levels
with diabetic retinopathy prevalence in the U.S. population: Implications for diabetes
diagnostic thresholds.
Diabetes Care 2009 Nov;32(11):2027-32.
8.
Klein R, Sharrett AR, Klein BE, Chambless LE, Cooper LS, Hubbard LD, Evans G. Are
retinal arteriolar abnormalities related to atherosclerosis?: The Atherosclerosis Risk in
Communities Study.
Arterioscler Thromb Vasc Biol 2000 Jun;20(6):1644-50.
9.
McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, Klein BE, Wang JJ, Mitchell P,
Vingerling JR,
de Jong PT, Witteman JC, Breteler MM, Shaw J, Zimmet P, Wong TY.
Prediction of incident stroke events based on retinal vessel caliber: a systematic review and
individual-participant meta-analysis.
Am J Epidemiol 2009 Dec 1;170(11):1323-32.
10.
Klein R, Klein BE, Moss SE, Wong TY. Retinal vessel caliber and microvascular and
macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of
Diabetic Retinopathy.
Ophthalmology 2007 Oct;114(10):1884-92.
Section 5B - Data Collection (Phase 3 - 1/2011, rev. 8/2011)
Section 5B - Page 12
Cohort
Study
11.
Bayu SM, Wang JJ, Donaghue KC, Cheung N, itez-Aguirre P,
Jenkins A, Hsu W, Lee ML,
Wong TY. Alterations in Retinal Microvascular Geometry in Young Type 1 Diabetes.
Dostları ilə paylaş: